ArticleCureus2022

Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study.

Kapil D Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.